MATWIN 2027 Acceleration Program - Oncology
An accelerator program designed to evaluate and maximize the potential for technology transfer in oncology.
Through a structured support program, candidates will have access to expertise, coaching and mentoring, and a network of qualified partners who can help them accelerate the development of their project.
The program is open to international candidates (academic teams or startups) developing an innovative R&D product or solution in oncology in the areas of therapeutics, diagnostics, medical devices, medtech, technology platforms, and AI tools.
You are invited to join the webinar on October 20, 2026, at 12:30 p.m., featuring two former MATWIN program participants who will share their experiences with the program and explain how this support helped them develop and strengthen their projects.
MATWIN offers an accelerator program specifically designed to evaluate and maximize the potential for technology transfer in oncology.
Applications are due by November 20, 2026.